{"id":"NCT01814553","sponsor":"Boehringer Ingelheim","briefTitle":"ADAM-Afatinib Diarrhea Assessment and Management","officialTitle":"A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-04","primaryCompletion":"2015-07","completion":"2015-07","firstPosted":"2013-03-20","resultsPosted":"2016-10-31","lastUpdate":"2016-10-31"},"enrollment":40,"design":{"allocation":null,"model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Carcinoma, Non-Small-Cell Lung"],"interventions":[{"type":"DRUG","name":"afatinib","otherNames":[]},{"type":"DRUG","name":"loperamide","otherNames":[]}],"arms":[{"label":"Afatinib 40 mg + Loperamide (Cohort 1)","type":"EXPERIMENTAL"},{"label":"Afatinib 40 mg + loperamide prophylactic (Cohort 2)","type":"EXPERIMENTAL"}],"summary":"This is a non-randomized, open label, two-cohort, multi-institutional study to evaluate the use of diarrheal management tools intended to facilitate timely intervention and treatment modifications due to afatinib treatment-related diarrhea in patients with EGFR mutations-positive adenocarcinoma of the lung. Patients in Cohort 1 will follow diarrhea management. Patients in Cohort 2 will receive prophylactic loperamide starting the fist day of afatinib treatment.","primaryOutcome":{"measure":"Occurence of CTCAE Grade >= 2 Diarrhea","timeFrame":"From first drug administration until 28 days after the end of third treatment course, up to 84 days.","effectByArm":[{"arm":"Afatinib 40 mg + Loperamide (Cohort 1)","deltaMin":72.2,"sd":null},{"arm":"Afatinib 40 mg + Loperamide Prophylactic (Cohort 2)","deltaMin":31.8,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":12,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":10,"n":18},"commonTop":["Diarrhoea","Nausea","Dermatitis acneiform","Constipation","Stomatitis"]}}